CytomX Therapeutics (CTMX) EBITDA Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | CytomX Therapeutics | 638.18 Mn | 291.48 Mn | - | -16,396.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,396.00 |
| Dec 31, 2025 | -134,290.00 |
| Sep 30, 2025 | 2,001.00 |
| Jun 30, 2025 | 23,073.00 |
| Mar 31, 2025 | 40,741.00 |
| Dec 31, 2024 | 36,498.00 |
| Sep 30, 2024 | 35,405.00 |
| Jun 30, 2024 | 27,734.00 |
| Mar 31, 2024 | 31,755.00 |
| Dec 31, 2023 | 34,276.00 |
| Sep 30, 2023 | 34,709.00 |
| Jun 30, 2023 | 36,225.00 |
| Mar 31, 2023 | -5,081.00 |
| Dec 31, 2022 | 75,875.00 |
| Sep 30, 2022 | -3,528.00 |
| Jun 30, 2022 | 8,843.00 |
| Mar 31, 2022 | -28,104.00 |
| Dec 31, 2021 | -3,547.00 |
| Sep 30, 2021 | -14,921.00 |
| Jun 30, 2021 | -16,801.00 |
| Mar 31, 2021 | -17,437.00 |
| Dec 31, 2020 | -34,119.00 |
| Sep 30, 2020 | -29,389.00 |
| Jun 30, 2020 | -7,838.00 |
| Mar 31, 2020 | 10,827.00 |
| Dec 31, 2019 | -57,409.00 |
| Sep 30, 2019 | 20,442.00 |
| Jun 30, 2019 | 13,676.00 |
| Mar 31, 2019 | 63,607.00 |
| Dec 31, 2018 | 30,124.00 |
| Sep 30, 2018 | 42,498.00 |
| Jun 30, 2018 | 14,843.00 |
| Mar 31, 2018 | 24,694.00 |
| Dec 31, 2017 | 25,940.00 |
| Sep 30, 2017 | 14,518.00 |